Johnson & Johnson Sounds Alarm on TRC Capital Investment's Below-Market Mini-Tender Offer for Company Shares

Johnson & Johnson announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to...

April 05, 2024 | Friday | News
Blue Wolf Capital Partners to Acquire Seven European Manufacturing and Development Facilities from Recipharm

    The facilities, located in Solna, Stängnäs, Höganäs, Karlskoga, and Uppsala OTC Development in Sweden, Pessac in France...

April 03, 2024 | Wednesday | News
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

  Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company specializing in allosteric modulation-based drug development,...

April 03, 2024 | Wednesday | News
Gilead Sciences Completes Acquisition of CymaBay, Strengthening Liver Disease Therapies

    “The acquisition of CymaBay brings us a potential best-in-disease therapy that could transform the treatment landscape for people wit...

March 25, 2024 | Monday | News
AstraZeneca's Quantum Leap in Cancer Treatment: Acquires Fusion Pharmaceuticals for Next-Gen Radioconjugates

AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a trailblazing clinical-stage biopharmaceutical company speciali...

March 19, 2024 | Tuesday | News
AstraZeneca Set to Acquire Amolyt Pharma in a Deal Worth Up to $1.05 Billion

The deal, valued at up to $1.05 billion, comprises an $800 million upfront payment and an additional $250 million contingent upon r...

March 14, 2024 | Thursday | News
Willow Biosciences Secures Second Strategic Investment from Kalsec

Willow Biosciences, a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ing...

March 04, 2024 | Monday | News
FogPharma® Secures $145 Million in Series E Funding to Revolutionize Cancer Treatment with Pioneering Helicon™ Peptide Technology

FogPharma®, a clinical-stage biopharmaceutical company dedicated to delivering a new class of therapies that go beyond the limits of currently availabl...

March 04, 2024 | Monday | News
CoreRx, Inc. Set to Acquire Societal CDMO, Bolstering CDMO Sector Capabilities

This strategic acquisition marks a pivotal step towards creating a combined entity with expanded capabilities and a robust service offering that spans from...

February 29, 2024 | Thursday | News
Curve Therapeutics Secures £40.5 Million Series A Funding Led by Pfizer Ventures to Propel Cancer Drug Discovery Efforts

Curve Therapeutics, a pioneering biotechnology firm, announced a significant £40.5 million Series A funding round, led by Pfizer Ventures and joined ...

February 28, 2024 | Wednesday | News
Aizon Raises $20M in Series C Funding to Revolutionize Pharma Manufacturing

      Aizon, the AI SaaS provider transforming pharmaceutical manufacturing, announced today the closing of a $20 million...

February 09, 2024 | Friday | News
Novartis Bolsters Oncology Portfolio with MorphoSys AG Acquisition for EUR 2.7 Billion

The acquisition encompasses key assets such as pelabresib, a promising late-stage BET inhibitor for myelofibrosis (MF), and tulmimetostat, an early-stage i...

February 06, 2024 | Tuesday | News
Wegovy Producer Catalent Snapped Up in $16.5 Billion Deal by Novo Holdings

In a strategic shift that promises to redefine the pharmaceutical industry, Novo Holdings, the investment arm of Novo Nordisk's parent foundation, has unve...

February 05, 2024 | Monday | News
Alto's Brainy Bonanza: Neuroscience Powerhouse ANRO Unleashes $128.6M IPO Surge

In a move that adds an intriguing layer to the IPO dynamics, Alto has granted underwriters a 30-day option to scoop up an additional 1,206,000 shares of co...

February 02, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in